In8bio Valuation
| INAB Stock | USD 2.20 0.15 6.38% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. In8bio Inc owns a latest Real Value of $2.85 per share. The recent price of the firm is $2.2. Our model calculates the value of In8bio Inc from analyzing the firm fundamentals such as Shares Outstanding of 3.44 M, ebitda of (27.78 M), and Return On Asset of -0.73 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that In8bio's price fluctuation is very risky at this time. Calculation of the real value of In8bio Inc is based on 3 months time horizon. Increasing In8bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since In8bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of In8bio Stock. However, In8bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.2 | Real 2.85 | Hype 1.7 | Naive 1.8 |
The real value of In8bio Stock, also known as its intrinsic value, is the underlying worth of In8bio Inc Company, which is reflected in its stock price. It is based on In8bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of In8bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of In8bio Inc helps investors to forecast how In8bio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of In8bio more accurately as focusing exclusively on In8bio's fundamentals will not take into account other important factors: In8bio Total Value Analysis
In8bio Inc is currently forecasted to have valuation of 477.95 K with market capitalization of 8.09 M, debt of 5.03 M, and cash on hands of 25.74 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the In8bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
477.95 K | 8.09 M | 5.03 M | 25.74 M |
In8bio Asset Utilization
One of the ways to look at asset utilization of In8bio is to check how much profit was generated for every dollar of assets it reports. In8bio owns a negative utilization of current and long term assets of -0.73 %, losing $0.007325 for each dollar of current and long term assets held by the firm. Discouraging asset utilization attests that the company is being less competent with each dollar of current and long term assets it owns. Strictly speaking, asset utilization of In8bio Inc shows how wasteful it operates for each dollar spent on its current and long term assets.In8bio Ownership Allocation
In8bio owns 4.0 % of its outstanding shares held by insiders and 20.77 % owned by institutions.In8bio Profitability Analysis
Net Loss for the year was (30.44 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates In8bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in In8bio and how it compares across the competition.
About In8bio Valuation
The stock valuation mechanism determines In8bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of In8bio. We calculate exposure to In8bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of In8bio's related companies.IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York. In8Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.
In8bio Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 53.5 M |
Complementary Tools for In8bio Stock analysis
When running In8bio's price analysis, check to measure In8bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8bio is operating at the current time. Most of In8bio's value examination focuses on studying past and present price action to predict the probability of In8bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In8bio's price. Additionally, you may evaluate how the addition of In8bio to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |